Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtration
References (12)
- et al.
Purification and Characterization of Human Factor IX
Thromb. Res.
(1975) - et al.
Purification of antithrombin III by affinity chromatography
Thromb. Res.
(1974) - et al.
The separation of active and inactive forms of heparin
Biochem. Biophys. Res. Comm.
(1976) - et al.
Anticoagulant activity of Heparin: Separation of High-activity and Low-activity Heparin-species by affinity chromatography on immobilized Antithrombin
Febs Letters
(1976) Actions and Interactions of Antithrombin and Heparin
The New England J. of Med.
(1975)On the proteinase inhibitors of human plasma with special reference to antithrombin
There are more references available in the full text version of this article.
Cited by (399)
Update on pregnancy-associated venous thromboembolism
2022, Thrombosis UpdateHemostasis in Pediatric Extracorporeal Life Support: Overview and Challenges
2022, Pediatric Clinics of North AmericaAnticoagulation in preterm and term neonates: Why are they special?
2020, Thrombosis ResearchCitation Excerpt :However a recent single institution study in the NICU, found long term central access devices (Broviac catheters) to have a stronger association with thrombosis than short term access catheters (UVC's or PICC's) [9]. This study reported a median number of catheter days of 17 day [3–93] among CVC-related DVT cases compared to 10.5 days [1–65] among controls who had a CVC. The association of longer catheter duration (≥14 days) with thrombosis is also reported in another case control study [6].
Characterization of circulating plasma proteins in dairy cows with cytological endometritis
2019, Journal of Proteomics
Copyright © 1976 Published by Elsevier Ireland Ltd.